[1]
“RECOMBINANT CYTOKINES IN THE TREATMENT OF PNEUMONIA. CLINICAL EXPERIENCE”, Medicine, vol. 2, no. 1, pp. 49–51, Jun. 2021, doi: 10.26577/IAM.2021.v2.i1.02.